
N. Anthony Coles
individual
About
N. Anthony Coles, M.D., M.P.H., is an American physician and biotechnology executive who served as chief executive officer of Cerevel Therapeutics and remained its chairperson after stepping down as CEO in 2023. His career has included senior leadership roles at biotech and pharmaceutical companies, and he has held public-company and nonprofit board seats including Regeneron Pharmaceuticals, CRISPR Therapeutics, and Johns Hopkins. Public SEC filings also show substantial personal equity wealth tied to Cerevel.
Areas of interest
biotechlife scienceshealthcare investingneuroscienceneurodegenerative diseaseoncologyhealth equitycivic leadership